Stephan Toutain
Chief Operating Officer presso ANAVEX LIFE SCIENCES CORP.
Profilo
Stephan Toutain is currently the Senior Vice President-Operations at Anavex Life Sciences Corp.
He previously worked as the General Manager at Alexion Pharmaceuticals, Inc. from 2009 to 2011, Head-Global Commercial Development at Sarepta Therapeutics, Inc. from 2014 to 2015, and Chief Commercial Officer at Interleukin Genetics, Inc. from 2016 to 2017.
He has a graduate degree from Nancy-Université and an MBA from The University of North Carolina at Charlotte.
Posizioni attive di Stephan Toutain
| Società | Posizione | Inizio |
|---|---|---|
| ANAVEX LIFE SCIENCES CORP. | Chief Operating Officer | 05/03/2018 |
Precedenti posizioni note di Stephan Toutain
| Società | Posizione | Fine |
|---|---|---|
| INTERLEUKIN GENETICS, INC | Corporate Officer/Principal | 01/08/2017 |
| SAREPTA THERAPEUTICS, INC. | Corporate Officer/Principal | 01/01/2015 |
| ALEXION PHARMACEUTICALS, INC. | Corporate Officer/Principal | 01/01/2011 |
Formazione di Stephan Toutain
| Nancy-Université | Graduate Degree |
| The University of North Carolina at Charlotte | Masters Business Admin |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Società quotate in Borsa | 2 |
|---|---|
| SAREPTA THERAPEUTICS, INC. | Health Technology |
| ANAVEX LIFE SCIENCES CORP. | Health Technology |
| Aziende private | 2 |
|---|---|
Alexion Pharmaceuticals, Inc.
 Alexion Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Alexion Pharmaceuticals, Inc. engages in the business of serving patients and families affected by rare diseases and devastating conditions through the discovery, development, and commercialization of life-changing medicines. The firm also focuses on the development of haematology, nephrology, neurology, metabolic disorders, cardiology, and ophthalmology. The company was founded by Joseph A. Madri, David W. Keiser, Stephen P. Squinto, and Leonard Bell in January 1992 and is headquartered in Boston, MA. | Health Technology |
Interleukin Genetics, Inc.
 Interleukin Genetics, Inc. Pharmaceuticals: MajorHealth Technology Interleukin Genetics, Inc. engages in the marketing and development of proprietary genetic tests for chronic inflammatory diseases and health-related conditions focuses on metabolism and inflammation. The company was founded in 1986 and is headquartered in Waltham, MA. | Health Technology |
- Borsa valori
- Insiders
- Stephan Toutain
